Pathogenesis of the cardiometabolic risk in youth with type 1 diabetes
Diabetes Mellitus - Type 1
What is the purpose of this trial?
The purpose of this study is to quantitate hepatic de novo lipogenesis (DNL) in youth with poorly-controlled type 1 diabetes (T1D) (HbA1c >8.5%), youth with T1D who achieve targeted glycemic control (HbA1c <7.5%) and lean controls. Hypothesis: Youth with poor glycemic control experience higher fractional hepatic DNL during the fasting and the postprandial states than youth who achieve targeted glycemic control and lean controls.
- Ages13 - 22 years
- Trial withNational Institute of Diabetes and Digestive & Kidney Diseases (NIDDKD)
- Start Date11/19/2019
- End Date03/30/2021
- Last Updated12/06/2019
- Study HIC#2000025170